Amgen halts clinical studies of its stomach-cancer drug By: L.A. Biz via Business Journals November 25, 2014 at 14:57 PM EST Biotech company Amgen Inc. said it is ending late-stage clinical studies of its experimental stomach-cancer treatment because of patient deaths... Read More >>